Copper peptide hair growth: GHK-Cu
A human trial did count more hairs. Its mixture contained GHK and another active ingredient, so the preparation deserves a closer look before the peptide gets all the credit.
The copper peptide hair growth study
The controlled human trial followed 45 men with androgenetic alopecia, or pattern hair loss, for six months. Their loss was classified as Norwood-Hamilton II–V. The topical preparation combined 5-aminolevulinic acid with glycyl-histidyl-lysine, the GHK peptide.
I favour the stubborn practicality of counting hairs. The study gives copper peptide hair growth a more useful starting point than a collection of photographs. It also makes attribution awkward: the investigators tested a combination, so the finding cannot establish the effect of GHK-Cu alone.
Hair-count changes at six months
The trial reported average hair-count increases of 52.6 with the 100 mg/mL preparation and 71.5 with the 50 mg/mL preparation, compared with 9.6 for placebo. Both active groups differed significantly from placebo at p<0.05. No adverse events were reported in any group.
The concentrations refer to the studied combination. The decimal counts are group averages. A six-month count also leaves a reader's earlier question unanswered: the paper supplies no validated onset interval for a visible change.
The larger average gain occurred with the lower tested concentration. That uneven response deserves an explanation, especially in a small trial of a mixed preparation. A repeat testing the individual ingredients could clarify which component contributed and whether this pattern recurs.
Follicle biology and DHT
The tissue-remodelling review describes GHK-Cu effects on supporting tissue and signals involved in blood-vessel growth across experimental models. Such work supplies plausible questions about a follicle's surroundings. It stops short of demonstrating hair regrowth in a person.
The human combination trial did not establish a DHT-blocking mechanism. Its hair counts therefore give no basis for describing GHK-Cu as a DHT blocker. DHT is the androgen associated with common male pattern hair loss.
Beef liver and copper
Does beef liver connect to this research? GHK was originally isolated from human plasma in work involving aged liver tissue, as described in the skin-regeneration review. That discovery concerned protein synthesis in laboratory tissue.
The hair trial tested a topical GHK combination in men. It did not test beef liver, dietary copper or a copper supplement. None of the studies collected here establishes beef liver as a way to reproduce its hair-count result.
What scalp-serum users noticed and what remains unknown
People using copper peptide scalp serums report less hair fall within one to two months and thicker-looking hair over three to six months. Many combine a serum with scalp needles or other products, so no one part clearly caused the change.
These accounts come from users, not a controlled trial. Researchers haven’t checked the changes or the timing. You won’t find a strength, schedule, or routine here.
The controlled trial counted hairs at six months [4], but it didn’t say when a change began. User stories fill that blank with what people felt or saw, so they deserve less trust than a measured result.
The how does copper peptide work page explains the lab findings. The copper peptide benefits page lists reports and cautions. Reading both helps you separate what is known from what remains a guess.
Away from scalp-serum stories, Promise Peptides (mypromise.com) prescribes its GHK-Cu product after a review of the person's circumstances by its U.S.-licensed clinician, who may decide against a prescription. Its clinicians see U.S. patients exclusively, with the patient's state and requested treatment determining which options they can consider. Its compounded GHK-Cu has no FDA approval. That availability does not add evidence for hair growth.
Getting the peptide to the follicle
A hair-root cell in a dish has direct access to whatever the investigator adds. A scalp preparation has to cross skin. The topical review identifies poor passive penetration of native GHK as a central problem and discusses approaches intended to improve delivery.
In excised human skin, investigators measured copper passing through skin and remaining within it after a GHK-Cu preparation was applied. Those measurements establish copper movement in that apparatus. Intact-peptide delivery to a living follicle remains a separate question.
A follow-up testing GHK-Cu alone, with delivery described carefully, could separate the peptide's contribution from the rest of the preparation. There is currently no approved GHK-Cu treatment for hair loss, and neither an effective human strength nor a reliable time to regrowth follows from these studies.